VELOSULIN HUMAN: INSULIN HUMAN INJECTION.
The INSULIN HUMAN INJECTION is a the manufacturer industrial component. Key specifications include administration: SUBCUTANEOUS, special_features: DERIVED FROM PORCINE SOURCE WITH ENZYME ALTERATIONS TO ACHIEVE INSULIN IDENTICAL TO HUMAN INSULIN, raw_material_source: PORCINE INTESTINAL MUCOSA, primary_container_type: VIAL, therapeutic_equivalent: NOT LISTED, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-239-2460, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | SUBCUTANEOUS |
| special_features | DERIVED FROM PORCINE SOURCE WITH ENZYME ALTERATIONS TO ACHIEVE INSULIN IDENTICAL TO HUMAN INSULIN |
| raw_material_source | PORCINE INTESTINAL MUCOSA |
| primary_container_type | VIAL |
| therapeutic_equivalent | NOT LISTED |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 10.000 MILLILITERS |
| active_medicament_medicinal_strength | 100.000 UNITS INSULIN PER MILLILITER |
| NSN | 6505-01-239-2460 |
| THERAPEUTIC EQUIVALENT | NOT LISTED |
| ADMINISTRATION | SUBCUTANEOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | DERIVED FROM PORCINE SOURCE WITH ENZYME ALTERATIONS TO ACHIEVE INSULIN IDENTICAL TO HUMAN INSULIN |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 UNITS INSULIN PER MILLILITER |
| RAW MATERIAL SOURCE | PORCINE INTESTINAL MUCOSA |
No substitute or cross-reference records for this part.